Study number 8539-034
Dates
Feb 17 2025-May 13 2025
Location
Dallas, Texas
Age
18-65
Gender
Both Males and Females
Compensation
$12,736
Group
C3a OR C3b
The investigational drug in this research study is being developed for the treatment of vitiligo, a disease that causes loss of skin color in patches, and related autoimmune disorders. This is the first time that this study drug is being given to humans.
Fortrea Dallas, Tx is recruiting for:
-Healthy Men and Women, age 18-65
-Body Mass Index between 18-32
-Study involves 1 stay of 7 nights & 8 follow-up visits
-Compensation up to $12,736 may be provided for time and participation
-Refer a friend to receive $350 per qualified referral
*Females must be of nonchildbearing potential
Pt A C3a:
Check-in: Feb 17
Check-out: Feb 24
Follow-up: Feb 27, Mar 4, 11, 18, Apr 1, 15, 29, May 13
Pt A C3b:
Check-in: Feb 18
Check-out: Feb 25
Follow-up: Feb 28, Mar 5, 12, 19, Apr 2, 16, 30, May 14